Coronavirus channel feed

Up­dat­ed: Eu­ro­pean Com­mis­sion au­tho­rizes No­vavax's up­dat­ed Covid vac­cine

Last month
Pharma
FDA+

Like Mod­er­na, pan­dem­ic peers Pfiz­er and BioN­Tech head to PhI­II with Covid/flu com­bo jab

Last month
R&D
Pharma

Pfiz­er sets Paxlovid price at $1,390 for five-day course

Last month
Pharma

BioN­Tech ex­pects up to $950M in Covid vac­cine write-offs af­ter Pfiz­er low­ers ex­pec­ta­tions

Last month
Financing

Mod­er­na's new Covid-19 vac­cine analy­sis 'giv­ing weight' to an­nu­al boost­ing in­ter­val, com­pa­ny says

2 months ago
Pharma

Mod­er­na eyes PhI­II start for com­bo mR­NA jab tar­get­ing Covid and flu af­ter PhI/II suc­cess

2 months ago
R&D

FDA clears No­vavax’s fall boost­er for Covid-19, weeks af­ter mR­NA vac­cine boost­ers 

2 months ago
Pharma
FDA+

Ex-Warp Speed vac­cine leader nabs NextGen funds for Mod­eX Ther­a­peu­tics’ Covid-19 an­ti­bod­ies

2 months ago
Deals

What about No­vavax? Vac­cine com­pa­ny's boost­er is left out of FDA ac­tion on Pfiz­er, Mod­er­na shots

3 months ago

Bernie Sanders lifts hold on NIH nom­i­nee fol­low­ing Re­gen­eron price con­ces­sions

3 months ago
People

Mod­er­na touts broad­er an­ti­body da­ta on up­dat­ed Covid vac­cine as it gears up for fall roll­out

3 months ago
R&D

Bavar­i­an Nordic aban­dons Covid boost­er af­ter da­ta show it's not as ef­fec­tive against new vari­ants

3 months ago
R&D

Pfiz­er and BioN­Tech 'ready to ship' up­dat­ed Covid-19 vac­cine in EU on heels of CHMP rec­om­men­da­tion

3 months ago
Pharma

CEPI to in­vest up to $80M on ChA­dOx vac­cine plat­form, pre­vi­ous­ly used in As­traZeneca/Ox­ford Covid jab

3 months ago
Financing

WHO se­cures three li­cens­ing deals to boost Covid vac­cine and as­say prod­uct op­tions

3 months ago
Deals
Manufacturing

Drug­mak­ers pull back af­ter Covid boom, plan­ning to cut costs as they pre­pare for in­dus­try’s next era

4 months ago
R&D
Pharma

No­vavax plans to have up­dat­ed Covid vac­cine to mar­ket by Sep­tem­ber — but will it be ready in time?

4 months ago
Pharma

Born out of Omega push for pan­dem­ic treat­ments, Aeri­um Ther­a­peu­tics en­ters long Covid R&D

4 months ago
Startups
R&D

CSPC to launch Paxlovid ver­sion in Chi­na; SEC charges ex-Pfiz­er em­ploy­ee with in­sid­er trad­ing

5 months ago
China
Law

Eu­ro­pean Com­mis­sion so­lid­i­fies vac­cine man­u­fac­tur­ing plans to pre­pare for fu­ture health emer­gen­cies

5 months ago
Pharma

VRB­PAC unan­i­mous­ly rec­om­mends mono­va­lent, XBB lin­eage for next fal­l's Covid-19 vac­cine cam­paign

5 months ago
FDA+

FDA lays out what to ex­pect at ad­com­m's se­lec­tion of strains for Covid-19 vac­cine cam­paign this fall

6 months ago
FDA+

Eu­ro­pean Com­mis­sion to re­ceive few­er Pfiz­er-BioN­Tech vac­cine dos­es un­der amend­ed con­tract

6 months ago
Pharma

More than a year af­ter its emer­gency au­tho­riza­tion, FDA ful­ly ap­proves Pfiz­er's Covid pill Paxlovid for adults

6 months ago
FDA+
1234 Next page Last page
A service from the Financial Times